Comprehensive review of patients with hypercoagulable state in rheumatoid arthritis and strategies to reduce readmission rates: A retrospective cohort study based on protective exploration of traditional Chinese medicine

被引:0
|
作者
Li, Yang [1 ,2 ]
Liu, Jian [1 ,3 ]
Hu, Yuedi [1 ,2 ]
Cong, Chengzhi [1 ,2 ]
Chen, Yiming [1 ,2 ]
Wang, Fanfan [1 ,2 ]
机构
[1] Anhui Univ Chinese Med, Affiliated Hosp 1, Dept Rheumatol, Hefei 230031, Peoples R China
[2] Anhui Univ Chinese Med, Clin Med Sch 1, Hefei, Peoples R China
[3] Anhui Acad Chinese Med, Inst Rheumatol, Hefei, Peoples R China
关键词
hypercoagulable state; readmission; retrospective cohort study; rheumatoid arthritis; traditional Chinese medicine; XINFENG CAPSULE; INFLAMMATION;
D O I
10.1097/MD.0000000000040890
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to investigate the effect of traditional Chinese medicine (TCM) intervention on the risk of readmission and laboratory indicators in patients with rheumatoid arthritis hypercoagulable state. In the retrospective cohort design, patients with RA hospitalized between June 2013 and June 2021 at the First Affiliated Hospital of Anhui University of Chinese Medicine were followed up by telephone. Propensity score matching (PSM) was used to balance deviations in baseline information between patients in the hypercoagulable (HC) and non-hypercoagulable (Non-HC) groups, with exposure defined as receiving TCM treatment for >= 1 month. Cox proportional hazards model and Kaplan-Meier survival curves were employed to determine the factors influencing the readmission of RA-HC patients. Mantel test and association rule analysis was used to explore the relationship between the included factors and laboratory indicators. A total of 1169 cases were successfully followed up, including 831 RA-HC patients. 1:2 PSM yielded 311 patients in the non-HC group versus 535 patients in the HC group. We observed that the incidence of readmission and surgical treatment was significantly higher in the HC group than in the non-HC group, while the incidence of readmission, surgical treatment, and all-cause mortality was much lower in the exposed group than in the non-exposed group (all P < .05). Based on the Cox proportional risk model, we identified age above 60 years, Sjogren's syndrome, neutrophil count, and neutrophil-lymphocyte ratio (NLR) as risk factors for readmission, with TCM playing a protective role. The Kaplan-Meier survival curves further showed that the risk of readmission in the high-exposure subgroup was markedly lower than that of the low-exposure subgroup. Furthermore, the Mantel test highlights an intrinsic correlation between coagulation markers and other markers such as erythrocyte sedimentation rate (ESR) and hypersensitive c-reactive protein (hs-CRP), which are dramatically influenced by gender, age, etc. In addition, association rule analysis revealed a strong correlation between TCM and non-readmission, as well as improvement in rheumatoid factor, hs-CRP, ESR, platelet count, and NLR in RA-HC patients. As a promising therapeutic strategy, TCM with sufficient intensity and duration interventions can effectively reduce the risk of readmission and relieve laboratory indicators in RA-HC patients.
引用
收藏
页数:15
相关论文
共 25 条
  • [11] Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: A nationwide population-based study
    Huang, Ming-Cheng
    Pal, Fu-Tzu
    Lin, Che-Chen
    Chang, Ching-Mao
    Chang, Hen-Hong
    Lee, Yu-Chen
    Sun, Mao-Feng
    Yen, Hung-Rong
    JOURNAL OF ETHNOPHARMACOLOGY, 2015, 176 : 9 - 16
  • [12] Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study
    Tam, Hong-Wei
    Chen, Chyong-Mei
    Leong, Pui-Ying
    Chen, Chao-Hsi
    Li, Yuan-Chao
    Wang, Yu-Hsun
    Lin, Li-Chi
    Chiou, Jeng-Yuan
    Wei, James Cheng-Chung
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (08) : 1591 - 1599
  • [13] Experiences of Chinese Rheumatoid Arthritis Patients Who Chose Western Medicine, Traditional Chinese Medicine, and a Combination of Treatments: A Study Based on Interviews and Thematic Analysis
    Hu, Ying
    Zhu, Wenhui
    Wang, Xiaocong
    Yu, Yuefan
    Shi, Kangle
    Meng, Qinggang
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 1423 - 1433
  • [14] Traditional Chinese Medicine Decoctions Significantly Reduce the Mortality in Severe and Critically Ill Patients with COVID-19: A Retrospective Cohort Study
    Sun, Qin-Guo
    An, Xue-Dong
    Xie, Ping
    Jiang, Bo
    Tian, Jia-Xing
    Yang, Qian
    Li, Xiu-Yang
    Luo, Meng
    Liu, Ping
    Zhao, Sheng-Hui
    Duan, Li-Yun
    Lang, Su-Ping
    Fan, An
    Luo, Peng-Cheng
    Lian, Feng-Mei
    Huang, Xiao-Dong
    Tong, Xiao-Lin
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2021, 49 (05): : 1063 - 1092
  • [15] Experiences of Chinese Rheumatoid Arthritis Patients Who Chose Western Medicine, Traditional Chinese Medicine, and a Combination of Treatments: A Study Based on Interviews and Thematic Analysis [Letter]
    Jiang, Yilin
    Samah, Narina A.
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 2107 - 2108
  • [16] Adding Chinese Herbal Medicine to Routine Care is Associated With a Lower Risk of Rheumatoid Arthritis Among Patients With Asthma: A Population-Based Retrospective Cohort Study
    Chang, Wei-Chiao
    Livneh, Hanoch
    Chen, Wei-Jen
    Hsieh, Chang-Cheng
    Wang, Yu-Han
    Lu, Ming-Chi
    Guo, How-Ran
    Tsai, Tzung-Yi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [17] Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study
    Shi, Qi
    Liu, Shanshan
    Li, Wen
    Zong, Shaoqi
    Han, Susu
    Yang, Wei
    Li, Hongjia
    Hou, Fenggang
    ONCOTARGET, 2017, 8 (08) : 13488 - 13495
  • [18] Traditional Chinese medicine use is associated with lower risk of pneumonia in patients with systemic lupus erythematosus: a population-based retrospective cohort study
    Wang, Weijie
    Wang, Yu-Hsun
    Yang, Kepeng
    Ye, Xiangsheng
    Wang, Xinchang
    Wei, James Cheng-Chung
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [19] Clinical effects of traditional Chinese herbal medicine management in patients with COVID-19 sequelae: A hospital-based retrospective cohort study in Taiwan
    Hsieh, Po-Chun
    Yu, Chih-Chin
    Tzeng, I-Shiang
    Hsieh, Tsung-Han
    Wu, Chiu-Feng
    Ko, Li -Fan
    Lan, Chou -Chin
    Chao, You -Chen
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (07): : 1280 - 1291
  • [20] The risk of coronary artery disease in patients with rheumatoid arthritis using Chinese herbal products and conventional medicine in parallel: a population-based cohort study
    Han-Hua Yu
    Nai-Huan Hsiung
    Jen-Huai Chiang
    Hsuan-Shu Shen
    BMC Complementary Medicine and Therapies, 20